Neurocrine Biosciences
NBIX
#1452
Rank
โ‚น1.007 T
Marketcap
โ‚น9,951
Share price
-4.07%
Change (1 day)
6.71%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): โ‚น162.41

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is โ‚น165.46. In 2022 the company made an earnings per share (EPS) of โ‚น135.92 an increase over its 2021 EPS that were of โ‚น80.20.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น162.4119.49%
2022โ‚น135.9269.47%
2021โ‚น80.20-78.21%
2020โ‚น368.07990%
2019โ‚น33.7781.82%
2018โ‚น18.57-113.5%
2017-โ‚น137.600.62%
2016-โ‚น136.7657.28%
2015-โ‚น86.9525.61%
2014-โ‚น69.2218.84%
2013-โ‚น58.25-1085.71%
2012โ‚น5.91-89.71%
2011โ‚น57.41-500%
2010-โ‚น14.35-86.92%
2009-โ‚น109.75-43.48%
2008-โ‚น194.17-57.8%
2007-โ‚น460.0992.58%
2006-โ‚น238.91371.67%
2005-โ‚น50.65-52.76%
2004-โ‚น107.2136.56%
2003-โ‚น78.51-70%
2002-โ‚น261.70118.31%
2001-โ‚น119.888.4%
2000-โ‚น110.5948.86%
1999-โ‚น74.29-20%
1998-โ‚น92.86-479.31%
1997โ‚น24.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น176.44 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น46.43-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น249.88-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น458.34 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น310.72 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น157.02-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น39.68-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น255.79-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA